The “What’s New with You?” Professional Breakfast Series is a group of workshops in Boston and Fairfield, CT, presented by Mountainside and a consortium of first rate treatment providers to share the latest developments in mental health, substance use disorders, and treatment advances. In this video, Dr. Mark Green, Addiction Psychiatrist at Psych Garden, discusses buprenorphine and the need for Medication-Assisted Treatment.
Dr. Mark Green Transcript
Some people are not in favor of using buprenorphine as a treatment for opioid addiction. What is your response to those people?
You know there’s a whole set of beliefs that you can’t have a deep recovery when you’re on buprenorphine, and I don’t know what to say about that. You don’t have a deep recovery if you’re dead. Buprenorphine treatment saves lives, is highly effective, reduces illicit drug use, and people who are maintained on buprenorphine for a year are 75 plus percent more likely to abstain from illicit drug use, and people who don’t have closer to zero.
What do you think that the root causes of prior failure to prescribe and treat with buprenorphine are?
I think that there’s ignorance and stigma. There’s ignorance about the fact that buprenorphine should be prescribed at the dose which is correct for the patient–where their use, cravings, and withdrawal are blocked, and where they are comfortable. And there is no deadline for how long it should be maintained for. A lot of physicians still work from a place where they wrongly think that patients should only be on a low dose for a short amount of time.
Any final words?
There are people who I won’t prescribe buprenorphine for. There are nuances of who I deem might be able to avoid marinated in an opioid for a long period of time. Those are the ones who are not truly opiate dependent. If they are on the edge, I think, great let’s see what we can do. Because when you commit someone to buprenorphine you are marinating them in opiates. If they weren’t opiate dependent beforehand they will be by the time they’re done. So, it’s not something to give to everyone, just like you don’t give every borderline diabetic insulin when they walk in through the door.